Here's how you can gauge the success of your R&D projects with key metrics.

Publications, patents products with maximum customer reach across the globe. Publications with citations in national and international journals

-Normally R&D projects are considered as cost center -ROI of 20% and above shows a good return -Payback period of 3 years considered acceptable (industry specific) -NPV must be positive(>0) over 10 years at discount rate of 10 or 12%. Higher number is better -Current investment must have higher return than the opportunity cost

You're right. ROI is a valuable tool for assessing R&D projects, but it has limitations. While it considers costs and financial gains, it might not capture the long-term benefits of R&D, such as new knowledge, improved processes, or a competitive edge.

Si instalamanos barreras de seguridad, en cualquier instancia, para ejercer control, disminuir da?os patrimoniales y no entregar facilmente todo a las compa?ías aseguradoras, que nos subirán las primas, un incidente puede marcar la diferencia y lo da?ado o perjudicado tuvo un costo mayor que la inversion que apliqué al inicio. No Inverti nada porque no habia dinero, me robaron 500 y lo pase por el seguro que respondió, pero me subio la prima en 200......mi inversion era 100 para evitar todo ese da?o al patrimonio....es necesario creer en lo justo que uno invertirá en beneficio y no en detrimento de la empresa.

Since many research efforts do not contribute directly to ROI, but almost always contribute to growth in knowledge, ROI is best measured on an overall basis - looking at all returns relative to all costs. Generally, ROI based only on a successful initiative is misleading, since it ignores all the failed and low return initiatives.

-TM (time to market) should be 36 months in chemical but in Pharmaceutical and medicine it is higher -Timesheet on resources spent must be maintained and tracked -Accolade type tracking of projects progress is essential for timely completion of project -Stage/Gate system should be implemented to monitor the status of projects

Depends on what the R&D is about - if its pure sciences, then the mere act of filling gaps in our fundamental knowledge would be a success. However, in industrial R&D i would say that the success factors are the R&D touching the market (deployed) and creates value for the organisation. The number of IPs generated for the R&D (and accolades - if any) and the timeline to mature the R&D from an idea to the field (depending on the type of R&D - the time varies)

Time tracking is a valuable tool for R&D project management. It helps identify areas for improvement and optimize resource allocation.

- Number of PDL(patent disclosure) and IP protection filing are the key measures of project impact -Maintenance of patent protects the company asset -Implementation of project in actual field/plants to number of patent filings should be tracked -Patent maintenance cost is high, therefore short list high quality projects

Número y calidad... nos quedamos con calidad sin duda. La verdad es que es un mundo complejo, una mezcla de técnica recubierta de complejos procedimientos jurídicos, aquí toca realizar un buen examen de lo que hemos intentado proteger, por ello siempre realizar una adecuada búsqueda del estado de la técnica y definir previamente y en lo posible nuestra futura posibilidad de operar en los mercados, con esto nuestras métricas se orientarán a la explotación... además os pregunto ?qué es lo contarías en una patente y de que forma? una buena planificación y estrategia os audaran a que vuestras patentes sean se calidad

Patent metrics are valuable tools for assessing a company's innovative output. They can provide insights into the novelty, market potential, and influence of an organization's R&D efforts.

Sí, nada como analizar los mercados, aquí por mi experiencia hemos de trabajar mucho la presentación de nuestros proyectos, las personas somos bien diferentes y cabe gestar un equipo más allá de la parte técnica, de hecho se les debería consultar antes de empezar a investigar... y siempre el mejor de los prototipos para testear, bello, sencillo... llegados a este punto es común que tras tanto esfuerzo en I+D+i no pongamos el cari?o y conocimiento necesario en esta parte, ya sabeis cómo le gusta criticar al consumidor ;)

Customer adoption and market share are key metrics for gauging the market impact of R&D projects. Successful R&D goes beyond creating new products; it's about delivering solutions that address customer needs and preferences. By analyzing market reception, you can assess the real-world effectiveness of your innovations. Strong adoption and rising market share signal that your R&D efforts are hitting the mark.

I believe market impact is the greatest measure of R&D success. This is much more important than patents and publications. Generally, market impact should also be a predictor of ROI. However, if ROI is low and market impact is huge, that is generally an indication of poor execution in R&D or from R&D to market.

Evaluating process improvements is essential for ensuring the efficiency of your R&D function. Here are some ways to measure these improvements: * Speed: Track the time it takes to complete different stages of the R&D process, such as ideation, prototyping, and testing. * Cost: Monitor the cost of R&D activities, including personnel costs, materials, and equipment. * Quality: Assess the quality of R&D outputs, such as the number of successful product launches or patents filed.

Understanding team dynamics is crucial for optimizing biotech R&D. Effective restructuring requires deep insights into existing team dynamics, emphasizing the need for objective psychological analyses. These help identify not only skill gaps but also crucial personality and work style alignments. In recruitment, assessing soft skills and cultural fit is as important as technical expertise to ensure new hires enhance team cohesion and productivity, rather than disrupt it.

Según mi experiencia, definitivamente, en investigación, desarrollo y ejecución de proyectos y participación es vital que la dinámica de colaboración en los equipos genere mayores resultados esperados y a mayores escalas. Totalmente de acuerdo en que el fomento de creatividad, dinámica de cooperación eficaz y desarrollo interpersonal brinda mayores posibilidades de crecimiento y compromiso.

Very simple - how much revenue did the project generate and at what margin? Did it increase margin versus the product it replaced? Did it create new sales above the average margin for products in a similar family.